Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

26.52USD
10 Dec 2018
Change (% chg)

$0.24 (+0.91%)
Prev Close
$26.28
Open
$26.30
Day's High
$27.98
Day's Low
$26.23
Volume
134,394
Avg. Vol
--
52-wk High
$35.55
52-wk Low
$21.67

Chart for

About

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein... (more)

Overall

No Ratios Available.

Financials

  ALLO.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -- -- --
ROI: -- 0.28 15.02
ROE: -- 0.94 16.60

Earnings vs. Estimates